Esperion Therapeutics: 2Q Earnings Snapshot
ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Thursday reported a loss of $54.2 million in its second quarter.
On a per-share basis, the Ann Arbor, Michigan-based company said it had a loss of $2.01.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.86 per share.
The biopharmaceutical company posted revenue of $982,000 in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $933,000.
Esperion Therapeutics shares have fallen 16% since the beginning of the year. The stock has fallen 17% in the last 12 months.